相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Current strategies to target p53 in cancer
Fang Chen et al.
BIOCHEMICAL PHARMACOLOGY (2010)
mRNA display selection of a high-affinity, Bcl-XL-specific binding peptide
Nobutaka Matsumura et al.
FASEB JOURNAL (2010)
Structure-based Design of High Affinity Peptides Inhibiting the Interaction of p53 with MDM2 and MDMX
Jason Phan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The p53 orchestra: Mdm2 and Mdmx set the tone
Mark Wade et al.
TRENDS IN CELL BIOLOGY (2010)
Making Strides in Peptide-Based Therapeutics
Danielle A. Guarracino et al.
CHEMISTRY & BIOLOGY (2009)
Crystal Structures of Human MdmX (HdmX) in Complex with p53 Peptide Analogues Reveal Surprising Conformational Changes
Joerg Kallen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Diverse backbone-cyclized peptides via codon reprogramming
Takashi Kawakami et al.
NATURE CHEMICAL BIOLOGY (2009)
Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX
Marzena Pazgiera et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Awakening guardian angels: drugging the p53 pathway
Christopher J. Brown et al.
NATURE REVIEWS CANCER (2009)
Targeting the MDM2-p53 interaction for cancer therapy
Sanjeev Shangary et al.
CLINICAL CANCER RESEARCH (2008)
Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer
Sanieev Shangary et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition
Sanjeev Shangary et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Efficient p53 activation and apoptosis by simultaneous disruption of binding to MDM2 and MDMX
Baoli Hu et al.
CANCER RESEARCH (2007)
Regulating the p53 pathway:: in vitro hypotheses, in vivo veritas
Franck Toledo et al.
NATURE REVIEWS CANCER (2006)
Determinants of specificity of MDM2 for the activation domains of p53 and p65: Proline27 disrupts the MDM2-binding motif of p53
Susan Carr Zondlo et al.
BIOCHEMISTRY (2006)
A highly flexible tRNA acylation method for non-natural potypeptide synthesis
H Murakami et al.
NATURE METHODS (2006)
In vitro evolution of proteins
Tomoaki Matsuura et al.
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2006)
Current strategies for the development of peptide-based anti-cancer therapeutics
C Borghouts et al.
JOURNAL OF PEPTIDE SCIENCE (2005)
Ribosomal synthesis of unnatural peptides
K Josephson et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
The role of alpha-helical structure in p53 peptides as a determinant for their mechanism of cell death: necrosis versus apoptosis
R Rosal et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Discovery and cocrystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells
BL Grasberger et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Encodamers: Unnatural peptide oligomers encoded in RNA
A Frankel et al.
CHEMISTRY & BIOLOGY (2003)
Highly stable and efficient mRNA templates for mRNA-protein fusions and C-terminally labeled proteins
E Miyamoto-Sato et al.
NUCLEIC ACIDS RESEARCH (2003)
Inhibiting the p53-MDM2 interaction:: An important target for cancer therapy
P Chène
NATURE REVIEWS CANCER (2003)
A cell-free protein synthesis system for high-throughput proteomics
T Sawasaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Study of the cytotoxic effect of a peptidic inhibitor of the p53-hdm2 interaction in tumor cells
P Chène et al.
FEBS LETTERS (2002)
P53: An ubiquitous target of anticancer drugs
MV Blagosklonny
INTERNATIONAL JOURNAL OF CANCER (2002)
Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells
M Kanovsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Design of the linkers which effectively separate domains of a bifunctional fusion protein
R Arai et al.
PROTEIN ENGINEERING (2001)
MdmX binding to ARF affects Mdm2 protein stability and p53 transactivation
MW Jackson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The tandem affinity purification (TAP) method:: A general procedure of protein complex purification
O Puig et al.
METHODS (2001)
分享论文
